Hartley, David <br/><br/>
Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.  [electronic resource] 

 -  Journal of cellular biochemistry  2002 
 - 304-14 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0730-2312 
<br/><br/><label>Standard No.: </label>10.1002/jcb.10135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells--drug effects<br/>Adipocytes--metabolism<br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Becaplermin<br/>Electrophoretic Mobility Shift Assay<br/>Enzyme Inhibitors--pharmacology<br/>Fibroblasts--drug effects<br/>Hypoglycemic Agents--pharmacology<br/>Immunoblotting<br/>Insulin--pharmacology<br/>Insulin Receptor Substrate Proteins<br/>Mice<br/>Okadaic Acid--pharmacology<br/>Phosphoprotein Phosphatases--antagonists & inhibitors<br/>Phosphoproteins--genetics<br/>Platelet-Derived Growth Factor--pharmacology<br/>Protein Kinases--physiology<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins<br/>Proto-Oncogene Proteins c-akt<br/>Proto-Oncogene Proteins c-sis<br/>Ribosomal Protein S6 Kinases--metabolism<br/>Sirolimus--pharmacology<br/>TOR Serine-Threonine Kinases